JPRN-UMIN000015144已完成2 期
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung Cancer - Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung Cancer
Fukuoka University School of Medicine0 个研究点目标入组 40 人开始时间: 2014年9月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active severe comorbidity disease. 2) Interstitial pneumonia or pulmonary fibrosis on chest CT scans. 3) Patients with symptomatic Brain metastases. 4) Active concomitant malignancy. 5) Active infectious disease. 6) Pregnant or breast-feeding females. 7) Unstable psychic disorder. 8) Accepted continuous use of steroid. 9) Inappropriate patients for this study judged by the physicians.
研究者
相似试验
已完成
2 期
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
已完成
2 期
A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancerThymic cancerJPRN-UMIN000001358West Japan Oncology Group40
已完成
2 期
Phase2 study of Carboplatin / Nab-paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussionon-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussion in stage4JPRN-UMIN000013329Osaka Prefectural Medical Center for Respiratory and Allergic diseases20